Wire · opportunities
MiniMed gets FDA nod for tubeless insulin pump
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 17 November 2026 · Fusion42 review
MiniMed received FDA clearance for its first tubeless insulin pump, MiniMed Fit, which can be worn up to seven days and holds 300 units of insulin, targeting people with Type 1 and Type 2 diabetes aged seven and older. MiniMed Fit will compete with Insulet and Tandem Diabetes Care, with a planned phased U.S. rollout in spring 2027.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 16 Nov 2026 and 17 Nov 2026.
◆ ◆ The Wire takeaway
You now face more competition in tubeless insulin pumps as MiniMed enters with a longer-wear, larger-capacity device. Prepare to differentiate your diabetes care solutions on user convenience and insulin capacity.
◆ Coverage
3 sources · first reported 16 Nov 2026 · latest 17 Nov 2026
◆ Related on Wire
◆ Topics